These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26367070)

  • 1. Presence of the HLADR13 allele among Mexican Mestizos suggests a protective factor against relapsing-remitting multiple sclerosis (RRMS).
    Flores J; Granados J; Alonso E; Rito Y; Ortega-Hernández E; Mena-Hernández L; Corona T
    Clin Neurol Neurosurg; 2015 Nov; 138():184-7. PubMed ID: 26367070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mediterranean and Amerindian MHC class II alleles are associated with multiple sclerosis in Mexicans.
    Aláez C; Corona T; Ruano L; Flores H; Loyola M; Gorodezky C
    Acta Neurol Scand; 2005 Nov; 112(5):317-22. PubMed ID: 16218914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of apolipoprotein E epsilon4 genotype on brain tissue integrity in relapsing-remitting multiple sclerosis.
    De Stefano N; Bartolozzi ML; Nacmias B; Zipoli V; Mortilla M; Guidi L; Siracusa G; Sorbi S; Federico A; Amato MP
    Arch Neurol; 2004 Apr; 61(4):536-40. PubMed ID: 15096402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A link between promoter polymorphisms of the transforming growth factor β1 (TGFB1) and TGF-β1 receptor II (TGFBR2) genes and relapsing-remitting multiple sclerosis.
    Grigorova A; Trenova A; Stanilova S
    Folia Neuropathol; 2020; 58(4):307-316. PubMed ID: 33480235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic differences between primary progressive and relapsing-remitting multiple sclerosis: The impact of immune-related genes variability.
    Kiselev I; Bashinskaya V; Baulina N; Kozin M; Popova E; Boyko A; Favorova O; Kulakova O
    Mult Scler Relat Disord; 2019 Apr; 29():130-136. PubMed ID: 30711878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histocompatibility antigen (HLA) associations with multiple sclerosis in Iran.
    Kalanie H; Kamgooyan M; Sadeghian H; Kalanie AR
    Mult Scler; 2000 Oct; 6(5):317-9. PubMed ID: 11064440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran.
    Abolfazli R; Samadzadeh S; Sabokbar T; Siroos B; Armaki SA; Aslanbeiki B; Ghelman M; Taheri T; Shakoori A
    J Neurol Sci; 2014 Oct; 345(1-2):92-6. PubMed ID: 25064442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A longitudinal observation of brain-derived neurotrophic factor mRNA levels in patients with relapsing-remitting multiple sclerosis.
    Liguori M; Fera F; Patitucci A; Manna I; Condino F; Valentino P; Telarico P; Cerasa A; Gioia MC; di Palma G; Quattrone A
    Brain Res; 2009 Feb; 1256():123-8. PubMed ID: 19071096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of -330 interleukin-2 gene polymorphism and HLA-DR15 allele in Iranian patients with multiple sclerosis.
    Sayad A
    Int J Immunogenet; 2014 Aug; 41(4):330-4. PubMed ID: 24919928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DR association with the genetic susceptibility to develop ashy dermatosis in Mexican Mestizo patients.
    Correa MC; Memije EV; Vargas-Alarcón G; Guzmán RA; Rosetti F; Acuña-Alonzo V; Martínez-Rodríguez N; Granados J
    J Am Acad Dermatol; 2007 Apr; 56(4):617-20. PubMed ID: 17116345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL12B gene polymorphisms have sex-specific effects in relapsing-remitting multiple sclerosis.
    Miteva L; Trenova A; Slavov G; Stanilova S
    Acta Neurol Belg; 2019 Mar; 119(1):83-93. PubMed ID: 30554348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OAS1: a multiple sclerosis susceptibility gene that influences disease severity.
    O'Brien M; Lonergan R; Costelloe L; O'Rourke K; Fletcher JM; Kinsella K; Sweeney C; Antonelli G; Mills KH; O'Farrelly C; Hutchinson M; Tubridy N
    Neurology; 2010 Aug; 75(5):411-8. PubMed ID: 20679634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of HLA-DRB1 allele heterogeneity on disease risk and clinical course in a West Australian MS cohort: a high-resolution genotyping study.
    Wu JS; James I; Wei Qiu ; Castley A; Christiansen FT; Carroll WM; Mastaglia FL; Kermode AG
    Mult Scler; 2010 May; 16(5):526-32. PubMed ID: 20207784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIRs and their HLA ligands in remitting-relapsing multiple sclerosis.
    Fusco C; Guerini FR; Nocera G; Ventrella G; Caputo D; Valentino MA; Agliardi C; Gallotti J; Morra VB; Florio C; Clerici M; Lombardi ML
    J Neuroimmunol; 2010 Dec; 229(1-2):232-7. PubMed ID: 20826009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 7 Receptor Alpha Gene Variants Are Correlated with Gene Expression in Patients with Relapsing-remitting Multiple Sclerosis.
    Sayad A; Omrani MD; Solgi G; Noroozi R; Arsang-Jang S; Inoko H; Taheri M
    Iran J Allergy Asthma Immunol; 2017 Aug; 16(4):338-346. PubMed ID: 28865414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gulf War illness (GWI) as a neuroimmune disease.
    Georgopoulos AP; James LM; Carpenter AF; Engdahl BE; Leuthold AC; Lewis SM
    Exp Brain Res; 2017 Oct; 235(10):3217-3225. PubMed ID: 28762055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating the role of brain-derived neurotrophic factor in relapsing-remitting multiple sclerosis.
    Liguori M; Fera F; Gioia MC; Valentino P; Manna I; Condino F; Cerasa A; La Russa A; Clodomiro A; Paolillo A; Nisticò R; Vercillo L; Cittadella R; Quattrone A
    Genes Brain Behav; 2007 Mar; 6(2):177-83. PubMed ID: 16740142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DRB1 alleles encoding the "shared epitope" are associated with susceptibility to developing rheumatoid arthritis whereas HLA-DRB1 alleles encoding an aspartic acid at position 70 of the beta-chain are protective in Mexican Mestizos.
    Ruiz-Morales JA; Vargas-Alarcón G; Flores-Villanueva PO; Villarreal-Garza C; Hernández-Pacheco G; Yamamoto-Furusho JK; Rodríguez-Pérez JM; Pérez-Hernández N; Rull M; Cardiel MH; Granados J
    Hum Immunol; 2004 Mar; 65(3):262-9. PubMed ID: 15041166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Soluble Human Leukocyte Antigen-G (sHLA-G) Isoforms and Regulatory T Cells in Relapsing-Remitting Multiple Sclerosis.
    Alsahebfosoul F; Zavaran Hosseini A; Salehi R; Etemadifar M; Esmaeil N; Jamshidian A
    Iran J Allergy Asthma Immunol; 2015 Jun; 14(3):298-305. PubMed ID: 26546899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-DRB1 does not have a role in clinical response to interferon-beta among Iranian multiple sclerosis patients.
    Samadzadeh S; Tabibian E; Sabokbar T; Shakoori A; Dehgolan SR; Armaki SA; Aslanbeigi B; Abolfazli R
    J Neurol Sci; 2015 May; 352(1-2):37-40. PubMed ID: 25824849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.